HCPLive Network

Evidence for Strong Genetic Selection Against Some Psychiatric Disorders

 
FRIDAY, Jan. 4 (HealthDay News) -- Different evolutionary mechanisms likely support the persistence of various psychiatric disorders, according to a study published in the January issue of JAMA Psychiatry.

Robert A. Power, from King's College London, and colleagues measured the fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse versus their unaffected siblings and the general population in order to assess the level of selection on causal genetic variants. Data were obtained from the Swedish Multi-Generation Register and the Swedish Hospital Discharge Register for 2.3 million individuals in the 1950 to 1970 birth cohort.

The researchers found that affected patients had significantly fewer children (fertility rate range from 0.23 to 0.93), with the exception of women with depression. The reduction in fecundity was greater among men than women. Sisters of patients with schizophrenia and bipolar disorder had significantly increased fecundity, while brothers of patients with schizophrenia and autism showed significantly lower fecundity. Fecundity was significantly increased among all siblings of patients with depression and substance abuse.

Our results suggest that strong selection exists against schizophrenia, autism, and anorexia nervosa and that these variants may be maintained by new mutations or an as-yet unknown mechanism," the authors write. "Vulnerability to depression, and perhaps substance abuse, may be preserved by balancing selection, suggesting the involvement of common genetic variants in ways that depend on other genes and on environment."

One author disclosed financial ties to the pharmaceutical industry.
 

Abstract
Full Text (subscription or payment may be required)

 
Copyright © 2013 HealthDay. All rights reserved.
 

Further Reading
Researchers at Hong Kong University and the Wellcome Trust Sanger Institute have identified a link between the influenza A viruses’ genetic diversity and severity of the infection.
Carol Burke, MD, FACG, FASGE, talks about her phase-3 placebo-controlled trial of Celecoxib in pediatric subjects with familial adenomatous polyposis (FAP) at the 2014 ACG Annual Meeting in Philadelphia, PA.
Carol Burke, MD, FACG, FASGE, discusses pediatric familial adenomatous polyposis (FAP) and colorectal cancer at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.
The immune system is the new focus of much work on traumatic brain injury (TBI). In a challenge to the paradigm that the blood brain barrier prevents harmful leukocytes from entering the brain, a Texas team tried to neutralize the impact of these cells. Peripheral lymphocytes are activated after TBI. They may then act as potential antigen presenting cells and get into the brain, causing cells there to degenerate.
Black women undergoing in vitro fertilization are only about half as likely as white women to become pregnant, and the racial disparity persists even when donor eggs are used. These findings are being presented at the annual meeting of the American Society for Reproductive Medicine, held from Oct. 18 to 22 in Honolulu.
Hospital conversion to for-profit status is associated with improvements in financial margins, but has no effect on process quality metrics or mortality rates, according to a study published in the Oct. 22/29 issue of the Journal of the American Medical Association
Drinking sugar-sweetened sodas may affect cellular aging by shortening telomere length, according to research published online Oct. 16 in the American Journal of Public Health.
More Reading